Skip Navigation

News & Events

Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

Questions and Answers

Sept. 30, 2013

Q&A: The PopART HIV Prevention Study (See News Release)

Apr. 25, 2013

Q&A: The HVTN 505 HIV Vaccine Regimen Study (see Statement)

July 24, 2012

Q&A: The ASPIRE HIV Prevention Study

July 18, 2012

Q&A: The NEXT-PrEP HIV Prevention Study (see News Release)

May 30, 2012

Q&A: The COAT Trial (see News Release)

Nov. 25, 2011

Q&A: The VOICE HIV Prevention Study (see Statement)

Sept. 30, 2011

Q&A: The VOICE HIV Prevention Study (see Statement)

May 12, 2011

Q&A: The HPTN 052 Study: Preventing Sexual Transmission of HIV with Anti-HIV Drugs (see News Release)

Dec. 13, 2010

Q&A: NIH Trial of 2009 H1N1 Influenza Vaccine in People with Asthma (see News Release)

Nov. 23, 2010

Q&A: The iPrEx Study: Pre-Exposure Prophylaxis as HIV Prevention Among Men who Have Sex with Men (see News Release)

Sept. 30, 2010

Q&A: The Herpevac Trial for Women (see News Release)

Oct. 16, 2009

Q&A: The NIH 2009 H1N1 Influenza Vaccine Trials in HIV-Infected Children, Youth and Pregnant Women (see News Release)

Oct. 16, 2009

Q&A: NIH Trial of 2009 H1N1 Influenza Vaccine in People with Asthma (see News Release)

Oct. 8, 2009

Q&A: Trial of a Candidate 2009 H1N1 Influenza Vaccine Plus Adjuvant
(see Bulletin)

Sept. 16, 2009

Q&A: The VOICE HIV Prevention Study

Sept. 9, 2009

Q&A: NIAID Trial of Candidate 2009 H1N1 Influenza Vaccine in Pregnant Women at the Vaccine and Treatment Evaluation Units
(see News Release)

Aug. 24, 2009

Q&A: The HVTN 505 HIV Vaccine Regimen Study
(see Bulletin)

Aug. 19, 2009

Q&A: Pediatric Trials of Candidate 2009 H1N1 Vaccine at NIAID Vaccine and Treatment Evaluation Units (VTEUs) (see Bulletin)

July 22, 2009

Q & A: Clinical Trials of 2009 H1N1 Influenza Vaccines Conducted by the NIAID-Supported Vaccine and Treatment Evaluation Units (see News Release)

June 8, 2009

Q & A: The CIPRA HT 001 Clinical Trial (see News Release)

Feb. 10, 2009

Q & A: The ESPRIT and SILCAAT HIV Treatment Clinical Studies (see News Release)

Feb. 9, 2009

Q & A: The HPTN 035 Study of Two Candidate Microbicides, BufferGel and PRO 2000 (0.5% dose) (see News Release)

Feb. 6, 2008

Q & A: Anti-Herpes Drug Does Not Reduce Risk of HIV Infection in People with Genital Herpes Virus, Study Finds (see News Release)

Sept. 21, 2007

Q & A: HVTN 502 and HVTN 503 HIV Vaccine Clinical Trials (updated Feb. 6, 2008) (see Statement) l En Espanol (PDF)

July 25, 2007

Q & A: CHER Study - Treating HIV-Infected Infants Early Helps Them Live Longer (see News Release)

Feb. 8, 2007

Q & A: Large-Scale HIV Vaccine Trial (HVTN 503) Opens in South Africa (see News Release)

February 2007

Q & A: Avian Influenza Trials

Nov. 29, 2006

Q & A: NEJM Article on the SMART Study: CD4+ Count-Guided Episodic Antiretroviral Therapy (see News Release)

June 29, 2006

Q & A: Leadership for the Newly Reorganized NIAID HIV/AIDS Clinical Trials Networks (see News Release)

June 29, 2006

Q & A: Adult Male Circumcision Trials in Kenya and Uganda (see Statement)

Jan. 18, 2006

Q & A: International HIV/AIDS Trial Finds Continuous Antiretroviral Therapy Superior to Episodic Therapy (see News Release)

July 14, 2005

Q & A: Center for HIV/AIDS Vaccine Immunology (CHAVI) (see News Release)

April 7, 2005

Q & A: The HIVNET 012 Study and the Safety and Effectiveness of Nevirapine in Preventing Mother-to-Infant Transmission of HIV (see Statement)

March 17, 2005

Q & A: Open Letter in Science Regarding NIH Biodefense Funding

Last Updated October 01, 2013